Oligodendroglioma Clinical Trials

65 clinical trials for Oligodendroglioma across international registries, including 14 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas — RECRUITING · PHASE2
• SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance) — RECRUITING · PHASE3
• Study of Olutasidenib and Temozolomide in HGG — RECRUITING · PHASE2
• PRO-GLIO: PROton Versus Photon Therapy in IDH-mutated Diffuse Grade II and III GLIOmas — RECRUITING · NA
• All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma — RECRUITING · PHASE2
• A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed Brain Tumors (Gliomas). — RECRUITING · PHASE3
• A Randomized Trial of Delayed Radiotherapy in Patients Low-grade Oligodendrogliomas Requiring a Treatment Other Than Surgery — RECRUITING · PHASE3
• Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms — RECRUITING · PHASE1
• Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age — RECRUITING · PHASE1
• HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer) — RECRUITING · NA
• FearLess in NeuroOncology — RECRUITING · NA
• Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology — RECRUITING
• Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNAlevel- Relapse and Clinical-relapse Oligodendroglioma — RECRUITING · PHASE2
• Efficacy of Post-radiation Adjuvant Temozolomide Chemotherapy in Residue Low-grade Glioma — RECRUITING · PHASE3
• Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive Disease — NOT_YET_RECRUITING · PHASE2
• Social Determinants of Health in Glioblastoma Population — COMPLETED
• Ketoconazole Before Surgery in Treating Patients With Recurrent Glioma or Breast Cancer Brain Metastases — TERMINATED · PHASE1
• Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma — ACTIVE_NOT_RECRUITING · PHASE2
• Safety and Efficacy Study of Safusidenib in Participants With Grade 2 IDH1-Mutant Glioma — NOT_YET_RECRUITING · PHASE3
• GliomaAI-Oligo: MRI-Based Detection of IDH Mutant Oligodendroglioma — COMPLETED
• Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma — WITHDRAWN · PHASE2
• Investigational Imaging Technique During Brain Surgery — SUSPENDED · NA
• Study of Vorasidenib and Pembrolizumab Combination in Recurrent or Progressive IDH-1 Mutant Glioma — ACTIVE_NOT_RECRUITING · PHASE1
• A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2 — ACTIVE_NOT_RECRUITING · PHASE1
• Pre-Radiation Chemotherapy for Newly Diagnosed High-Grade Glioma. — NOT_YET_RECRUITING · PHASE2
• Peds CHAMP1ON - Hematopoietic Stem Cell And Monoclonal Antibody PD-1 Blockade for RecurreNt Pediatric High-Grade Glioma — ACTIVE_NOT_RECRUITING · PHASE1
• CBT-I in Primary Brain Tumor Patients: Phase IIc Randomized Feasibility Pilot Trial — COMPLETED · PHASE2
• Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas — TERMINATED
• Prospective Evaluation of AI R&D Tool in Adult Glioma and Other Primary Brain Tumours (PEAR-GLIO) — TERMINATED
• Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients with Recurrent High-Grade Glioma — ACTIVE_NOT_RECRUITING · PHASE1
• Neo-adjuvant Evaluation of Glioma Lysate Vaccines in WHO Grade II Glioma — COMPLETED · PHASE1
• Safety and Efficacy of PD0332991 (Palbociclib), a Cyclin-dependent Kinase 4 and 6 Inhibitor, in Patients With Oligodendroglioma or Recurrent Oligoastrocytoma Anaplastic With the Activity of the Protein RB Preserved — COMPLETED · PHASE2
• Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors — TERMINATED · PHASE2
• Radiotherapy in IDH Mutated Glioma: Evaluation of Late Outcomes — COMPLETED
• A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG) — TERMINATED · PHASE1
• Ga-68 Prostate Specific Membrane Antigen PET/CT in Gliomas — OTHER · NA
• Hierarchical Diagnosis for Adult Diffuse Glioma Based on Deep Learning — OTHER
• Investigation of Oral OKN-007 in Recurrent High-grade Glioma Participants — WITHDRAWN · PHASE1
• Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors — COMPLETED · PHASE2
• RRx-001 + Radiation + Temozolomide In Newly Diagnosed Glioblastoma and Anaplastic Gliomas — COMPLETED · PHASE1
• Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors — COMPLETED
• Educating Brain Tumor Patients Using Patient-specific Actual-size Three-dimensional Printed Models — OTHER
• Proteomic Characterization of Aggressive Oligodendrogliomas — OTHER
• NovoTTF-200A Device in Treating Patients With Newly Diagnosed High Risk Oligodendroglioma — WITHDRAWN · NA
• The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) — OTHER
• Neural Basis of Language Processing — COMPLETED · NA
• Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patients With Recurrent Glioblastoma — WITHDRAWN · PHASE2
• First in Patient Study for PF-06840003 in Malignant Gliomas — TERMINATED · PHASE1
• Natural History of Patients With Brain and Spinal Cord Tumors — COMPLETED
• Genetic Analysis of Brain Tumors — TERMINATED

Refine this search